University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50-80
SponsorUniversity of Michigan
About this trial
The purpose of this study is to obtain new knowledge regarding screening for COPD. This study will use a participant's cancer screening CT scans performed as part of routine health care among current and former smokers at risk for COPD to identify participants who have had a spirometry or will have a spirometry test as part of the study to verify COPD status.
Eligibility criteria
Qualifiers
Eligible for lung cancer screening by USPSTF 2021 criteria including age 50-80 years and currently or formerly smoking with at last 20 pack-years of smoking history at the time of consent.
Willingness to participate in an observational clinical trial and to be contacted about future ancillary studies that could include interventional clinical trials.
Ability to tolerate study procedures.
Ability to provide informed consent.
Disqualifiers
The presence of a respiratory condition other than COPD or asthma, or of a comorbid condition that in the judgment of the investigator may be the principal cause of respiratory symptoms (e.g. dyspnea or decreased exercise tolerance).
Concurrent participation in a therapeutic trial where treatment is blinded.
Active pregnancy. Documentation of birth control will be required for pre-menopausal women.
Cognitive dysfunction that prevents the participant from completing study procedures.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
200 Participants
are grouped into 2 trial groupsSponsors and collaborators
University of Michigan
Lead sponsor
COPD Foundation
Collaborator
Source ClinicalTrials.gov